What is Advarra?
Advarra operates at the intersection of clinical trial safety and technological innovation. The company provides a comprehensive suite of services that includes trusted review solutions, regulatory compliance consulting, and advanced research management software. By serving as a central hub for life sciences companies, contract research organizations (CROs), and academic research sites, Advarra effectively streamlines the complex workflows inherent in modern drug development. Their market position is defined by a deep-seated commitment to safeguarding trial participants while simultaneously accelerating the pace of medical discovery through smarter, faster, and more compliant research methodologies.
How much funding has Advarra raised?
Advarra has raised a total of $1.8B across 1 funding round:
Debt
$1.8B
Debt (2022): $1.8B with participation from Genstar Capital
Key Investors in Advarra
Genstar Capital
Genstar Capital is a middle-market private equity firm that focuses on investing in high-quality companies across a range of industries, including financial services, software, industrials, and healthcare. The firm partners closely with management teams and strategic advisors to support the growth, transformation, and long-term success of its portfolio companies.
What's next for Advarra?
With this major enterprise-level funding, Advarra is well-positioned to expand its technological footprint and enhance its service delivery capabilities. The strategic allocation of this capital will likely focus on deepening the integration of its software platforms, thereby reducing friction for research sites and investigators. As the clinical trial landscape becomes increasingly digitized, Advarra's focus on compliance and operational efficiency will be paramount in maintaining its competitive advantage. Future growth initiatives will likely involve scaling its consulting expertise and expanding its reach into emerging therapeutic markets, ensuring that the company remains the preferred partner for organizations navigating the rigorous demands of modern clinical research.
See full Advarra company page
